The PBX1 gene (1q23) is the most common translocation partner for TCF3, resulting in TCF3/PBX1 gene fusion, and is currently classified in the WHO as a recurrent genetic abnormality in B-ALL/LBL4. Here, TCF3 is linked to acute lymphoblastic leukemia.